HPH MRD Personalized Cancer Detection with Ultra-High Sensitivity
HPH MRD is a truly personalized cancer detection test using whole genome sequencing to inform the test design and manufacturing process, delivering an ultra-high sensitivity test for every patient.
HPH MRD is performed in Germany and samples and data remain local.
HPH MRD is based on the technology of Haystack MRD® by Quest Diagnostics®.
MRD Testing Overview
Whole Genome Sequencing Technology
Ultra-High Sensitivity Detection Limits
Baseline and Monitoring Workflow
Clinical Use Case Indications
When to use HPH MRD?
Sample Processing Workflow
